John A. Roberts, Chief Executive Officer at CANCER GENETICS, INC (CGIX), bought 100,000 shares at $0.23 ($23K) on 2019-01-14, disclosed to the SEC on 2019-01-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| VYNT | BUY | 2021-05-27 | $50K | — | Filing → |
| CGIX | BUY | 2019-02-01 | $43K | — | Filing → |
| CGIX | BUY | 2017-12-18 | $24K | — | Filing → |